WRM
BMY icon

Weybosset Research & Management’s Bristol-Myers Squibb BMY Stock Holding History

Weybosset Research & Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,940
Closed -$406K – 53
2014
Q3 		$406K Buy
+7,940
New +$397K 0.27% 40

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weybosset Research & Management's BMY Position: Q4 2014 in Review

Weybosset Research & Management sold out of Bristol-Myers Squibb (BMY) in Q4 2014, closing a stake of 7,940 shares — an estimated $406K sold.

Weybosset Research & Management first reported a position in BMY in Q3 2014 and held it in 1 quarter. The position peaked at $406K in Q3 2014. 1,410 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Weybosset Research & Management reported no remaining Bristol-Myers Squibb position as of Q4 2014 after selling out during the quarter.
  • Weybosset Research & Management sold 7,940 Bristol-Myers Squibb shares in Q4 2014, an estimated $406K.
  • Weybosset Research & Management first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 1 quarter.
  • Weybosset Research & Management's Bristol-Myers Squibb position peaked at $406K in Q3 2014.
  • 1,410 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Weybosset Research & Management's 13F filing for Q4 2014, filed 3 Feb 2015.